CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

anatumomab mafenatox

mAbexperimentalADC

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

  • TAG72Immunity, passive

    TAG72 immunity, passive

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Payload
mafenatox

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • abr-214936
  • anatumomab mafenatox